Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137

Site search

Correspondence address
310 Mira Street, Stavropol, Russia, 355017

+7 8652 352524; +7 8652 353229.

+7 8652 352524.


Corrective effect of angiotensin-converting enzyme inhibitors on the daily profile of blood pressure and somnological characteristics in elderly patients with combined cardiac pathology

[Original research]
Mikhail Osadchuk; Inna N. Vasil`eva; Ekaterina Mironova; Anastasia A. Khudarova; Nikolay Korzhenkov;

In recent years, a particular approach to the treatment of elderly patients with combined cardiac pathology has been gaining importance. It is aimed at adequate antihypertensive therapy and correction of chronologically occurring circadian biorhythms to study the curative effect of ramipril on the daily blood pressure (BP) profile and somnological characteristics of elderly patients with arterial hypertension (AH) and coronary artery disease (CAD). In an outpatient setting, 57 patients with the 1st and 2nd degree of stage III essential AH in combination with angina pectoris (AP) 1 and 2 functional class (FC) were examined. Patients underwent general clinical, laboratory examination, daily monitoring of blood pressure, somnological questionnaire survey. The study results allowed us to conclude that ramipril has a significant corrective effect on the regular BP profile and somnological characteristics in patients with combined cardiac pathology.


1.Kelly B. B., Narula J., Fuster V. Recognizing global burden of cardiovascular disease and related chronic
diseases. Mt. Sinai. J. Med. 2012;79(6):632-640. https://doi.org/10.1002/msj.21345
2. Petrie J. R., Guzik T. J., Touyz R. M. Diabetes, Hypertension,and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can. J. Cardiol. 2018;34(5):575-584. https://doi.org/10.1016/j.cjca.2017.12.005
3. Touyz R. M., Anagnostopoulou A., De Lucca Camargo L., Montezano A. C. Novel Biosensors Reveal a Shift in the Redox Paradigm From Oxidative to Reductive Stress in Heart Disease. Circ. Res. 2016;119(9):969-971. https://doi.org/10.1161/CIRCRESAHA.116.309854
4. Dong Y., Yang F. M. Insomnia symptoms predict both future hypertension and depression. Prev. Med. 2019;123:41-47. https://doi.org/10.1016/j.ypmed.2019.02.001
5. Madsen M. T., Huang C., Zangger G., Zwisler A. D. O.,Gögenur I. Sleep Disturbances in Patients With Coronary Heart Disease: A Systematic Review. J. Clin. Sleep Med.2019;15(3):489-504. https://doi.org/10.5664/jcsm.7684
6. Scheen A. J. Clinical study of the month. The CAPPP study:«The Captopril Prevention Project». Rev. Med. Liege.1999;54(3):197-199.
7. Opie L. H. The new trials: AIRE, ISIS-4, and GISSI-3. Is the dossier on ACE inhibitors and myocardial infarction now complete? Cardiovasc. Drugs Ther. 1994;8(3):469-472.
8. Borghi C., Omboni S., Novo S., Vinereanu D., Ambrosio G.[et al.] Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study. Adv. Ther. 2018;35(5):604-618. https://doi.org/10.1007/s12325-018-0697-x
9. Torp-Pedersen C., Køber L. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation Lancet.1999;354(9172):9-12. https://doi.org/10.1016/s0140-6736(98)09374-x
10. Bertrand M. E., Ferrari R., Remme W. J., Simoons M. L.,Fox K. M. Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A European trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis. Am. Heart J. 2015;170(6):1092-1098. https://doi.org/10.1016/j.ahj.2015.08.018
11. Kübler W. ACE inhibitors in heart failure: effect on mode of death. Eur. Heart J. 1997;18(1):3-4. https://doi.org/10.1093/oxfordjournals.eurheartj.a015114
12. National Recommendations for the diagnosis and treatment of stable angina pectoris. Moscow 2009. Available at:https://scardio.ru/content/images/recommendation/rekomendacii_po_diagnostike_i_lecheniyu_stabilnoy_stenokardii.pdf. Accessed August 07, 2019.
13. Walczak-Gałęzewska M., Szulińska M., Miller-Kasprzak E.,Pupek-Musialik D., Bogdański P. The effect of nebivolol and ramipril on selected biochemical parameters, arterial stiffness, and circadian profile of blood pressure in young men with primary hypertension: A 12-week prospective randomized, open-label study trial. Medicine (Baltimore).2018;97(30):e11717. https://doi.org/10.1097/MD.0000000000011717
14. Gianni M., Bosch J., Pogue J., Probstfield J., Dagenais G.[et al.] Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients. Eur. Heart J. 2007;28(11):1382-8. https://doi.org/10.1093/eurheartj/ehm017
15. Parati G., Stergiou G., O’Brien E., Asmar R., Beilin L. [et al.] European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J. Hypertens.2014;32(7):1359-1366.
16. Vejn A. M., Levin Y. A. I. The principles of modern pharmacotherapy of insomnia. Journal of Neurology and Psychiatry.1998;2:45-49.
17. Morin C. M., Belleville G., Bélanger L., Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep.2011;34(5):601-608. https://doi.org/10.1093/sleep/34.5.601
18. Lonn E., Yusuf S., Dzavik V., Doris C., Yi Q. [et al.] Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 2001;103(7): 919-925. https://doi.org/10.1161/01.cir.103.7.919
19. Hall A. S., Murray G. D., Ball S. G. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy. Lancet.1997;349(9064):1493-1497. https://doi.org/10.1016/s0140-6736(97)04442-5
20. Chazova I. E., Ratova L. G. The role of 24-hour blood pressure monitoring in assessing the effectiveness of antihypertensive therapy (Results of 24-hour blood pressure monitoring in the CLIP-ACCORD program). Systemic hypertension.2007;1:18-26.
21. Kuliev F. A., Agaev M. M., Gusejnova A. A. Correction of central hemodynamic disorders in patients with kidney stone disease with arterial hypertension. Cardiology.1997;8:54-55.
22. Alyakrinskij B. S. Problems of latent desynchronosis. Cosmic biology and aerospace medicine. 1972;1:32–37.
23. Kostenko E. V., Petrova L. V., Eneeva M. A., Kamchatnov P. R. Disorders of sleep and circadian rhythms in diseases of the cardiovascular system. Journal of Neurology and Psychiatry. S. S. Korsakova.2015;115(3):30-36. Available at:https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-sikhiatrii-im-s-s-korsakova/2015/3/541997-72982015035. Accessed August 07, 2019. https://doi.org/10.17116/jnevro20151153130-36
24. Lichstein K. L., Taylor D. J., McCrae C. S., Petrov M. E. Insomnia: epidemiology and risk factors. In Kryger M. H., Roth T., Dement W. C. (eds.) Principles and Practice of Sleep Medicine. 6th ed. Philadelphia: «Elsevier», 2016:761-768.
25. Golenkov A. V., Poluektov M. G. The prevalence of sleep disorders among residents of Chuvashia (data from a continuous questionnaire). Journal of Neurology and Psychiatry.S. S. Korsakova. 2011;111(6):64-67.

Keywords: arterial hypertension, coronary artery disease, daily blood pressure profile, circadian biorhythms, somnological disorders

Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy